Widespread microbial invasion of the chorioamniotic membranes is a consequence and not a cause of intra-amniotic infection

Laboratory Investigation

Volumn 89, Issue 8, 2009, Pages 924-936

  Kim, Mi Jeong ^a   Romero, Roberto ^a,b   Gervasi, Maria Teresa ^c   Kim, Jung Sun ^a,b   Yoo, Wonsuk ^b   Lee, Deug Chan ^a   Mittal, Pooja ^a,b   Erez, Offer ^a,b   Kusanovic, Juan Pedro ^a,b   Hassan, Sonia S ^a,b   Kim, Chong Jai ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

16S rRNA; Amniotic fluid; Chorioamnionitis; Fluorescent in situ hybridization; Intra amniotic infection; Polymerase chain reaction

Indexed keywords

DNA 16S; RNA 16S;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CHORIOAMNIONITIS; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MAJOR CLINICAL STUDY; MYCOPLASMA HOMINIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UREAPLASMA UREALYTICUM;

ADOLESCENT; ADULT; AMNION; AMNIOTIC FLUID; CHORIOAMNIONITIS; CHORION; DELIVERY, OBSTETRIC; FEMALE; GESTATIONAL AGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; MYCOPLASMA; MYCOPLASMA INFECTIONS; NEUTROPHIL INFILTRATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, RIBOSOMAL, 16S; YOUNG ADULT;

EID: 68149164687     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.49     Document Type: Article

References (61)

1. Yoon BH, Romero R, Moon J, et al. Differences in the fetal interleukin-6 response to microbial invasion of the amniotic cavity between term and preterm gestation. J Matern Fetal Neonatal Med 2003;13:32-38.
2. Romero R, Yoon BH, Mazor M, et al. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169:839-851.
3. Coultrip LL, Lien JM, Gomez R, et al. The value of amniotic fluid interleukin-6 determination in patients with preterm labor and intact membranes in the detection of microbial invasion of the amniotic cavity. Am J Obstet Gynecol 1994;171:901-911.
4. Yoon BH, Romero R, Park JS, et al. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1998;179:1254-1260.
5. Romero R, Espinoza J, Goncalves LF, et al. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007;25:21-39.
6. Russell RB, Green NS, Steiner CA, et al. Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics 2007;120:e1-e9.
7. Hagberg H, Mallard C, Jacobsson B. Role of cytokines in preterm labour and brain injury. BJOG 2005;112(Suppl 1):16-18.
8. Romero R, Gotsch F, Pineles B, et al. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007;65:S194-S202.
9. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500-1507.
10. Yoon BH, Romero R, Kim M, et al. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 2000;183:1130-1137.
11. Berger A, Witt A, Haiden N, et al. Microbial invasion of the amniotic cavity at birth is associated with adverse short-term outcome of preterm infants. J Perinat Med 2003;31:115-121.
12. Galask RP, Varner MW, Petzold CR, et al. Bacterial attachment to the chorioamniotic membranes. Am J Obstet Gynecol 1984;148:915-928.
13. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988;31:553-584.
14. Goldenberg RL, Andrews WW, Hauth JC. Choriodecidual infection and preterm birth. Nutr Rev 2002;60:S19-S25.
15. Baergen RN. Manual of Benirschke and Kaufmann's pathology of the human placenta: Infectious Diseases. Springer: New York, 2005, pp 279-318.
16. Naeye RL, Ross S. Coitus and chorioamnionitis: a prospective study. Early Hum Dev 1982;6:91-97.
17. Pathology of the placenta. Infectious disorders of the placenta, 2nd edn. Churchill Livingstone: Philadelphia, 1999, p 317-342.
18. Benirschuke K, Kaufmann P, Baergen R. Pathology of the human placenta: Infectious diseases. 5th edn. Springer: New York, 2006, pp 657-761.
19. Steel JH, Malatos S, Kennea N, et al. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr Res 2005;57:404-411.
20. Redline RW. Placental inflammation. Semin Neonatol 2004;9:265-274.
21. Redline RW. Inflammatory responses in the placenta and umbilical cord. Semin Fetal Neonatal Med 2006;11:296-301.
22. Redline RW, Faye-Petersen O, Heller D, et al. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003;6:435-448.
23. Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet 2008;371:75-84.
24. Kempf VA, Trebesius K, Autenrieth IB. Fluorescent In situ hybridization allows rapid identification of microorganisms in blood cultures. J Clin Microbiol 2000;38:830-838.
25. Hogardt M, Trebesius K, Geiger AM, et al. Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J Clin Microbiol 2000;38: 818-825.
26. Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006;19:165-256.
27. Bottari B, Ercolini D, Gatti M, et al. Application of FISH technology for microbiological analysis: current state and prospects. Appl Microbiol Biotechnol 2006;73:485-494.
28. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005;353:1899-1911.
29. Melo AC, Almeida AM, Leal NC. Retrospective study of a plague outbreak by multiplex-PCR. Lett Appl Microbiol 2003;37:361-364.
30. Amann RI, Binder BJ, Olson RJ, et al. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 1990;56:1919-1925.
31. Nadkarni MA, Martin FE, Jacques NA, et al. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 2002;148:257-266.
32. Holt JG, Krieg NR, Sneath PHA, et al. Bergey's Manual of Determinative Bacteriology. Williams & Wilkins: Baltimore, 1994.
33. Yi J, Yoon B, Kim E. Detection and biovar discrimination of Ureaplasma urealyticum by real-time PCR. Mol Cell Probes 2005;19:255-260.
34. Mygind T, Zeuthen Sogaard I, Melkova R, et al. Cloning, sequencing and variability analysis of the gap gene from Mycoplasma hominis. FEMS Microbiol Lett 2000;183:15-21.
35. Eckmann L, Kagnoff MF. Intestinal mucosal responses to microbial infection. Springer Semin Immunopathol 2005;27:181-196.
36. Boulos L, Prevost M, Barbeau B, et al. LIVE/DEAD BacLight: application of a new rapid staining method for direct enumeration of viable and total bacteria in drinking water. J Microbiol Methods 1999;37:77-86.
37. Berney M, Hammes F, Bosshard F, et al. Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight Kit in combination with flow cytometry. Appl Environ Microbiol 2007;73: 3283-3290.
38. Corless CE, Guiver M, Borrow R, et al. Contamination and sensitivity issues with a real-time universal 16S rRNA PCR. J Clin Microbiol 2000;38:1747-1752.
39. Harris KA, Hartley JC. Development of broad-range 16S rDNA PCR for use in the routine diagnostic clinical microbiology service. J Med Microbiol 2003;52:685-691.
40. Blattner FR, Plunkett III G, Bloch CA, et al. The complete genome sequence of Escherichia coli K-12. Science 1997;277:1453-1474.
41. Uphoff CC, Drexler HG. Detection of mycoplasma in leukemia-lymphoma cell lines using polymerase chain reaction. Leukemia 2002;16:289-293.
42. Garner CM, Hubbold LM, Chakraborti PR. Mycoplasma detection in cell cultures: a comparison of four methods. Br J Biomed Sci 2000;57:295-301.
43. Blanc W. Pathways of fetal and early neonatal infection. Viral placentitis, bacterial and fungal chorioamnionitis. J Pediatr 1961;59:473-496.
44. Rosen DA, Hooton TM, Stamm WE, et al. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 2007;4:e329.
45. Ito T, Kobayashi D, Uchida K, et al. Helicobacter pylori invades the gastric mucosa and translocates to the gastric lymph nodes. Lab Invest 2008;88:664-681.
46. van der Waaij LA, Harmsen HJ, Madjipour M, et al. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis 2005;11:865-871.
47. Bacterial infections in the fetus and newborn infant. Bacterial colonization, 2nd edn. WB Saunders Company: Philadelphia, PA, 1984, pp 55-76.
48. Seong HS, Lee SE, Kang JH, et al. The frequency of microbial invasion of the amniotic cavity and histologic chorioamnionitis in women at term with intact membranes in the presence or absence of labor. Am J Obstet Gynecol 2008;199:375.e1-375.e5.
49. Zervomanolakis I, Ott HW, Hadziomerovic D, et al. Physiology of upward transport in the human female genital tract. Ann NY Acad Sci 2007;1101:1-20.
50. Hein M, Valore EV, Helmig RB, et al. Antimicrobial factors in the cervical mucus plug. Am J Obstet Gynecol 2002;187:137-144.
51. Gyr TN, Malek A, Mathez-Loic F, et al. Permeation of human chorioamniotic membranes by Escherichia coli in vitro. Am J Obstet Gynecol 1994;170:223-227.
52. El Khwad M, Stetzer B, Moore RM, et al. Term human fetal membranes have a weak zone overlying the lower uterine pole and cervix before onset of labor. Biol Reprod 2005;72:720-726.
53. El Khwad M, Pandey V, Stetzer B, et al. Fetal membranes from term vaginal deliveries have a zone of weakness exhibiting characteristics of apoptosis and remodeling. J Soc Gynecol Investig 2006;13: 191-195.
54. Hutzal CE, Boyle EM, Kenyon SL, et al. Use of antibiotics for the treatment of preterm parturition and prevention of neonatal morbidity: a metaanalysis. Am J Obstet Gynecol 2008;199: 620-628.
55. Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 2008;372:1319-1327.
56. Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 2008;372:1310-1318.
57. Romero R, Sibai B, Caritis S, et al. Antibiotic treatment of preterm labor with intact membranes: a multicenter, randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol 1993;169: 764-774.
58. Eschenbach DA, Nugent RP, Rao AV, et al. A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1991;164:734-742.
59. Klein LL, Gibbs RS. Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol 2004;190:1493-1502.
60. McGregor JA, French JI, Richter R, et al. Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment. Am J Obstet Gynecol 1990;163:1580-1591.
61. Lamont RF. Antibiotics for the prevention of preterm birth. N Engl J Med 2000;342:581-583.